Trials / Terminated
TerminatedNCT02975271
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Study of the Efficacy, Safety \& Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Serlopitant | |
| DRUG | Placebo | Matching placebo |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-01-17
- Completion
- 2017-01-17
- First posted
- 2016-11-29
- Last updated
- 2021-05-20
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02975271. Inclusion in this directory is not an endorsement.